Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Frontiers in Immunology
|
December 12, 2022
Genomic analysis of TNF-related genes with prognosis and characterization of the tumor immune microenvironment in lung adenocarcinoma
Hua Huang, Haochuan Yu, Xuanguang Li, et al.
Nutrients
|
January 11, 2025
Comparative Impact of Alternate-Day Fasting and Time-Restricted Feeding on Placental Function and Fetal Development in Maternal Obesity
Siyuan Liu, Lun Hua, Xi Mo, et al.
Journal of Animal Science and Biotechnology
|
January 16, 2022
Microbial and metabolomic mechanisms mediating the effects of dietary inulin and cellulose supplementation on porcine oocyte and uterine development
Zhaoyue Men, Meng Cao, Yuechan Gong, et al.
Cancer Medicine
|
October 12, 2024
Dihydroartemisinin Sensitizes Lung Cancer Cells to Cisplatin Treatment by Upregulating ZIP14 Expression and Inducing Ferroptosis
Zhuoying Yang, Zehao Zhou, Qingyu Meng, et al.
Cancer Science
|
June 9, 2025
Dauricine Overcomes Osimertinib Resistance in Lung Cancer by Inducing Ferroptosis via Stabilizing SAT1
Biying Men, Zhijie Chen, Haotian Ge, et al.
Plos Pathogens
|
March 19, 2026
Anatid herpesvirus 1 UL51 protein is palmitoylated by DHHC9 and DHHC18 for viral replication and virulence
Xiaolan Liu, Ruihao Zhang, Mingshu Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 2, 2015
Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors
Peilong Zhang, Jiaqiang Dong, Boyu Zhong, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 17, 2016
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors
Peilong Zhang, Jiaqiang Dong, Boyu Zhong, et al.
Cell Death & Disease
|
August 30, 2025
Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis
Meijuan Dian, Liang Yun, Qingyu Meng, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Frontiers in Immunology
|
December 12, 2022
Genomic analysis of TNF-related genes with prognosis and characterization of the tumor immune microenvironment in lung adenocarcinoma
Hua Huang, Haochuan Yu, Xuanguang Li, et al.
Nutrients
|
January 11, 2025
Comparative Impact of Alternate-Day Fasting and Time-Restricted Feeding on Placental Function and Fetal Development in Maternal Obesity
Siyuan Liu, Lun Hua, Xi Mo, et al.
Journal of Animal Science and Biotechnology
|
January 16, 2022
Microbial and metabolomic mechanisms mediating the effects of dietary inulin and cellulose supplementation on porcine oocyte and uterine development
Zhaoyue Men, Meng Cao, Yuechan Gong, et al.
Cancer Medicine
|
October 12, 2024
Dihydroartemisinin Sensitizes Lung Cancer Cells to Cisplatin Treatment by Upregulating ZIP14 Expression and Inducing Ferroptosis
Zhuoying Yang, Zehao Zhou, Qingyu Meng, et al.
Cancer Science
|
June 9, 2025
Dauricine Overcomes Osimertinib Resistance in Lung Cancer by Inducing Ferroptosis via Stabilizing SAT1
Biying Men, Zhijie Chen, Haotian Ge, et al.
Plos Pathogens
|
March 19, 2026
Anatid herpesvirus 1 UL51 protein is palmitoylated by DHHC9 and DHHC18 for viral replication and virulence
Xiaolan Liu, Ruihao Zhang, Mingshu Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 2, 2015
Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors
Peilong Zhang, Jiaqiang Dong, Boyu Zhong, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 17, 2016
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors
Peilong Zhang, Jiaqiang Dong, Boyu Zhong, et al.
Cell Death & Disease
|
August 30, 2025
Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis
Meijuan Dian, Liang Yun, Qingyu Meng, et al.
Page
of 7